Previous Close | 0.8044 |
Open | 0.8100 |
Bid | 0.7700 x 1000 |
Ask | 0.8112 x 3000 |
Day's Range | 0.7571 - 0.8390 |
52 Week Range | 0.5000 - 2.7300 |
Volume | |
Avg. Volume | 292,746 |
Market Cap | 38.981M |
Beta (5Y Monthly) | 1.89 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -4.2780 |
Earnings Date | May 10, 2023 - May 15, 2023 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 15.00 |
Progress in Three Phase 3 Trials in Areas of High Unmet Clinical Need, Including Positive Sorbitol Reduction Data from the Ongoing Phase 3 INSPIRE Trial in Sorbitol Dehydrogenase (SORD) Deficiency On Track to Report Additional Phase 3 Data Across Multiple Programs in 2023 NEW YORK, March 23, 2023 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indication
When a single insider purchases stock, it is typically not a major deal. However, when multiple insiders purchase...
NEW YORK, March 01, 2023 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced that it will participate in a Neuromuscular & Bone Panel at the Cowen 43rd Annual Health Care Conference on Wednesday, March 8, 2023 at 2:10 p.m. ET in Boston. Webcast information for this event will be accessible on the Events